Supporting the NHS, Supporting Healthcare Professionals, Supporting Patients

Servier Laboratories is committed to supporting the NHS and Healthcare Professionals (HCPs) to enhance the care of patients within the UK.  Servier's priority is to invest into clinical research which provides life changing treatments for patients with chronic conditions whilst also providing support to Healthcare Organisations (HCOs) through the provision of Medical and Educational Goods and Services. 


What are Medical and Educational Goods and Services or 'MEGS'?

MEGS are activities or the funding of activities, by industry, which are designed and intended to enhance patient care or benefit the NHS whilst maintaining patient care.  MEGS are unrelated to any promotional or commercial activities and may be provided subject to the regulations outlined in the Association of British Pharmaceutical Industry Code of Practice.  

Why does Servier support MEGS?

Servier's priority is to continue our research and development of new medicines to help patients.  Where finance and regulations allow us, supporting patients and healthcare professionals in the wider management of the conditions in which we conduct research is something we take great pride in.  Whilst Servier cannot fund all projects that support education or patient care we are only too pleased to consider them.

Activities we will consider are those with a clear benefit to patients or the NHS, are in line with our research areas (Oncology and Haematology) and are not requests for payments to any specific individual.  We would like to support as many HCOs as possible, so if your organisation has received support in the past it may not always be possible to provide support for subsequent years.

Supporting HCPs to attend educational conferences

Servier supports the education of UK HCPs by allocating a set budget to fund the attendance at educational conferences.  Funding of an individual HCP may be considered where there is a clear benefit to UK patients or the NHS.  Funding requests for a financial contribution to cover an individual's expenses to attend a conference, particularly if Servier is not in attendance, are unlikely to be accepted.  Retrospective requests for funding to attend a meeting will be rejected.

Applying to Servier for MEGS funding

If you represent a HCO or are a HCP operating within the NHS and are interested in applying for funding through a MEGS grant, please contact us at 

How are decisions to support MEGS made?

Requests for MEGS are reviewed by the MEGS committee on a monthly basis.  The MEGS committee is formed of senior employees from General Management, Regulatory Affairs, Medical Affairs and Compliance.

The following factors are taken into consideration -

  • clearly benefits patients
  • clearly benefits the NHS
  • related to an area of research in which Servier is active (Oncology and Haematology)
  • the level of funding requested
  • the MEGS budget available that month



UK17WEB0002(5) DoP: May 2019